Arnuity Ellipta in 2026: What's Going On with Availability?

If you've had trouble finding Arnuity Ellipta at your pharmacy recently, you might be wondering whether there's an official shortage. Dealing with medication availability issues is stressful enough when you have asthma — add uncertainty about what's actually happening and it becomes even worse.

In this article, we'll give you a clear, honest update on the Arnuity Ellipta supply situation in 2026, explain why you might be having trouble finding it, break down the current costs, and tell you exactly what you can do right now.

Is Arnuity Ellipta Still in Shortage?

As of March 2026, Arnuity Ellipta is not listed on the FDA's official drug shortage database. This means there is no recognized national shortage of this medication in the United States.

However, that doesn't mean you'll find it at every pharmacy. Many patients have reported difficulty locating Arnuity Ellipta at their local pharmacies, even though there's no formal shortage. There was a brief shortage reported in Canada in early 2024, but the US supply has remained officially stable.

The disconnect between "no official shortage" and "I can't find it anywhere" is a common frustration with prescription medications. There are several reasons this happens, which we'll explain below.

Why Is Arnuity Ellipta Hard to Find?

Even without a formal shortage, several factors can make Arnuity Ellipta difficult to locate:

Supply Chain Complexity

Arnuity Ellipta uses a specialized Ellipta dry powder inhaler device. Manufacturing these devices is more complex than producing pills or standard inhalers. Any disruption at the manufacturing level — raw material delays, quality control issues, or shipping problems — can ripple through to pharmacy shelves.

Insurance Formulary Changes

Some insurance plans have moved Arnuity Ellipta to a non-preferred tier or added step therapy requirements. When fewer patients in an area are prescribed Arnuity Ellipta, pharmacies reduce their stock, making it harder for the patients who do need it to find it.

Brand-to-Generic Transition

Prasco Laboratories launched an authorized generic version of Arnuity Ellipta in mid-2025. This transition period often creates temporary supply disruptions as pharmacies, wholesalers, and insurance plans adjust their stocking and coverage decisions. Some pharmacies may have stopped ordering the brand while waiting for the generic, or vice versa.

Regional Variation

Medication availability varies by region. Urban pharmacies with high patient volumes may keep Arnuity Ellipta in stock, while rural or suburban pharmacies may not carry it regularly. This isn't a shortage — it's a stocking decision based on local demand.

For a deeper look at why this medication can be hard to find, read our article on why Arnuity Ellipta is so hard to find.

How Much Does Arnuity Ellipta Cost in 2026?

Cost is often intertwined with availability. Here's what you can expect to pay for Arnuity Ellipta in 2026:

• Cash price (without insurance): $263 to $299 for one 30-day supply inhaler
• With GoodRx coupon: As low as approximately $137
• With insurance: Typical copays range from $25 to $75 per month, depending on your plan and tier
• GSK savings program: Eligible commercially insured patients may pay as little as $0 per fill through the GSK For You program

The authorized generic by Prasco may eventually offer lower pricing, though commercial availability and pricing are still being established in 2026. For detailed savings strategies, read our guide on how to save money on Arnuity Ellipta.

New Options in 2026

The biggest development for Arnuity Ellipta patients in 2026 is the authorized generic. Prasco Laboratories' authorized generic version of Fluticasone Furoate inhalation powder is the same medication in the same Ellipta device — it's just marketed under the generic name. This could help with both availability and cost over time.

Additionally, the broader inhaled corticosteroid market continues to offer alternatives if you can't find Arnuity Ellipta. Medications like Pulmicort Flexhaler (Budesonide), Flovent (Fluticasone Propionate), Qvar RediHaler (Beclomethasone), and Asmanex (Mometasone) are all proven options. See our full guide on alternatives to Arnuity Ellipta.

How to Find Arnuity Ellipta in Stock Right Now

If you need to fill your prescription today, here's what to do:

1. Check Medfinder: Use Medfinder to search for pharmacies near you that have Arnuity Ellipta in stock right now. It checks real-time inventory so you don't waste time calling around.
2. Ask about the generic: If a pharmacy doesn't have brand-name Arnuity Ellipta, ask if they carry the authorized generic Fluticasone Furoate inhalation powder by Prasco.
3. Try independent pharmacies: Smaller pharmacies often have more flexible ordering and may be able to get your medication faster.
4. Request a special order: Ask your pharmacist to order Arnuity Ellipta from their wholesaler. It often arrives within 1-2 business days.
5. Consider mail order: Check if your insurance offers a mail-order pharmacy option, which may have better stock for maintenance medications.

For more detailed strategies, see our article on how to find Arnuity Ellipta in stock near you.

Final Thoughts

While Arnuity Ellipta is not in an official shortage in 2026, real-world availability issues mean some patients still struggle to find it. The launch of an authorized generic, evolving insurance formularies, and supply chain logistics all play a role.

The most important thing is to stay on your asthma medication. If you can't find Arnuity Ellipta, use Medfinder to check stock, ask about the authorized generic, and talk to your doctor about alternatives if needed. Don't let a pharmacy stock-out turn into a gap in your asthma care.